FOR IMMEDIATE RELEASE

London, UK – 14 October 2024 – Verpora, in collaboration with Manatt Health, is pleased to announce that their recent webinar on the Medicare Drug Price Negotiation Program has been featured in an in-depth article by Pink Sheet, authored by Cathy Kelly.

The well-attended webinar, featuring experts from Verpora and Manatt Health, explored key lessons learned during the IPAY 2026 negotiations, strategic considerations for IPAY 2027, and essential dos and don’ts for pharmaceutical manufacturers preparing for future negotiations. Attended by over 20 of the world’s largest manufacturers, the event received high praise for its engaging and informative content.

Chris Webber, Head of Negotiation Strategy at Verpora, and Omar Ali, Head of Payers at Verpora, joined forces with Erin Hertzog and Ross Margulies, healthcare regulatory experts from Manatt Health, to deliver actionable strategies based on their real-world experiences navigating the complex Medicare Drug Price Negotiations.

The webinar is now available to stream on demand, offering a second chance for those who missed the live session to gain valuable insights from the experts.

Watch the full webinar here: Verpora On-Demand Webinar

About Verpora:
Verpora is a global leader in providing pharmaceutical manufacturers with tailored strategies and negotiation support in their interactions with government health systems, payers, and insurance companies. With a focus on innovative approaches, Verpora is at the forefront of supporting clients through complex regulatory and negotiation processes.

About Manatt Health:
Manatt Health is a division of Manatt, Phelps & Phillips, LLP, delivering legal and consulting services to healthcare organizations and manufacturers. Manatt Health’s expertise lies in navigating complex regulatory environments, ensuring their clients are well-prepared for challenges in the evolving healthcare landscape.

-ENDS-

Media Contact

E: communications@verpora.com